PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 74 filers reported holding PMV PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,526 | -36.2% | 9,532 | -34.9% | 0.00% | – |
| Q2 2023 | $91,703 | +195.0% | 14,649 | +124.7% | 0.00% | – |
| Q1 2023 | $31,091 | +35.2% | 6,518 | +245.2% | 0.00% | – |
| Q3 2022 | $23,000 | -43.9% | 1,888 | -33.6% | 0.00% | – |
| Q2 2022 | $41,000 | -14.6% | 2,842 | +23.4% | 0.00% | – |
| Q1 2022 | $48,000 | -81.1% | 2,303 | -79.1% | 0.00% | – |
| Q4 2021 | $254,000 | +25300.0% | 11,027 | +29702.7% | 0.00% | – |
| Q3 2021 | $1,000 | – | 37 | +311.1% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 9 | -99.7% | 0.00% | – |
| Q1 2021 | $103,000 | -76.4% | 3,107 | -56.1% | 0.00% | – |
| Q4 2020 | $436,000 | – | 7,083 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |